
|Articles|February 1, 2011
- Pharmaceutical Executive-02-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Advertisement
Articles in this issue
over 15 years ago
Skipping the Needle: Pharm Exec's Brand of the Yearover 15 years ago
Honing Reforms from Clinical Developmentover 15 years ago
Growing Stronger After the StormAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
The Future Relationship Between AI and Field Reps
4
BioNTech Terminates Phase II Clinical Trial for Cevumeran
5




